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Introduction {#cmi12624-sec-0001}
============

The fungal cell wall is essential to prevent lysis during growth and development. The cell wall of filamentous fungi is composed of several different carbohydrate polymers (chitin, β‐1,3‐glucan, β‐1,3/1,4‐glucan, α‐glucan and galactomannan) and glycoproteins (galactomannoproteins) (Guest and Momany, [2000](#cmi12624-bib-0058){ref-type="ref"}; Gastebois *et al*., [2009](#cmi12624-bib-0060){ref-type="ref"}; Free, [2013](#cmi12624-bib-0069){ref-type="ref"}). In *Aspergilli*, β‐1,3‐glucan together with chitin form the cell wall scaffold to which other components (galactomannan and α‐glucans) bind and are retained (Fontaine *et al.,* [2000](#cmi12624-bib-0019){ref-type="ref"}; Dichtl *et al.,* [2015](#cmi12624-bib-0013){ref-type="ref"}). The β‐1,3‐glucan also acts as a scaffold to cell wall proteins as the *A. niger*, cell wall protein A (CwpA) and at least six other cell wall proteins have been shown to be covalently linked to the β‐glucan part of the cell wall (Damveld *et al.,* [2005b](#cmi12624-bib-0009){ref-type="ref"}).

Attacks by compounds that inhibit cell wall synthesis or by cell wall‐degrading enzymes secreted by competing microorganisms or plants represent a serious threat for fungal survival. Fungi have developed several surviving strategies to cope with these threats. The best known strategy of cell wall reinforcement in response to cell wall stress is to activate the so‐called cell wall integrity (CWI) pathway. This pathway is studied in *Saccharomyces cerevisiae* in most detail, but is conserved in several other species, including *Aspergilli* (Levin, [2011](#cmi12624-bib-0063){ref-type="ref"}; Valiante *et al.,* [2015](#cmi12624-bib-0048){ref-type="ref"}). The CWI signalling pathway is composed of cell wall stress sensors, which generate a signal that activates a Rho‐Pkc1‐MAP kinase module, resulting in the activation of the Rlm1 and Swi4/6 transcription factors. These transcription factors are required for modulating gene expression in response to cell wall stress (see for review: Levin, [2011](#cmi12624-bib-0063){ref-type="ref"}). In *A. niger* the requirement of RlmA for the induction of the α‐glucan synthase A gene (*agsA*) in response to Calcofluor white has been established (Damveld *et al.,* [2005a](#cmi12624-bib-0008){ref-type="ref"}, [2005b](#cmi12624-bib-0009){ref-type="ref"}, [2005c](#cmi12624-bib-0011){ref-type="ref"}). Deletion of RlmA renders *A. niger* sensitive to Calcofluor white, and to a lesser extent also to other cell wall disturbing agents such as caspofungin (CA), aureobasidinA (AbaA), FK506 or fenpropimorph (FP), indicating that other remodelling mechanisms might exist (Fiedler *et al.,* [2014](#cmi12624-bib-0017){ref-type="ref"}). In the same study, transcription factor binding site enrichment analysis of differentially expressed genes in response to CA, AbaA, FK506 and FP was performed, which identified possible involvement of both RlmA and MsnA (homolog of Msn2/4 in *S. cerevisiae*) transcription factors in counteracting CA‐induced cell wall stress. Indeed, deletion of the MsnA transcription factor, like deletion of the RlmA transcription factor, led to increased susceptibility towards CA (Fiedler *et al.,* [2014](#cmi12624-bib-0017){ref-type="ref"}). MsnA has been shown to be required for coping with several stress responses, including osmotic and oxidative stress (Han and Prade, [2002](#cmi12624-bib-0024){ref-type="ref"}; Bose *et al.,* [2005](#cmi12624-bib-0005){ref-type="ref"}; Hong *et al.,* [2013](#cmi12624-bib-0027){ref-type="ref"}).

The observation that *agsA* expression is induced in response to cell wall stress was previously used to set up a mutant screen for cell wall mutants (Damveld *et al.,* [2008](#cmi12624-bib-0010){ref-type="ref"}). The rationale of this screen was that mutants with impaired cell wall strength, e.g. because of a mutation in a gene that encodes an enzyme involved in cell wall biosynthesis, would activate *agsA* expression. To isolate mutants showing constitutive activation of the *agsA* gene, the acetamidase reporter gene was cloned behind the *agsA* promoter, and mutants able to grow on acetamide were isolated. Using this screen, we identified the *ΔugmA* mutant, which lacks Gal*f* in its cell wall (Damveld *et al.,* [2008](#cmi12624-bib-0010){ref-type="ref"}; Park *et al.,* [2014](#cmi12624-bib-0036){ref-type="ref"}). The *ugmA* gene encodes a UDP‐galactopyranose mutase, which converts UDP‐galactopyranose to UDP‐galactofuranose (UDP‐Gal*f*). UDP‐Gal*f* is subsequently used for the synthesis of Gal*f*‐containing glycoconjugates such as cell wall galactomannan, *N*‐ and *O*‐glycans, and glycolipids (Tefsen *et al.,* [2012](#cmi12624-bib-0047){ref-type="ref"}).

In this study, we aimed at obtaining a broader view of understanding cell wall remodelling in the absence of Gal*f*‐glycoconjugate biosynthesis. We therefore used the *ΔugmA* mutant to perform a genome‐wide expression analysis using RNA‐seq to identify differentially expressed genes. As expected, among the genes induced in the *ΔugmA* mutant, the *agsA* gene was included, as well as several other genes whose function could be directly linked to cell wall biosynthesis. A transcription factor binding site enrichment analysis of genes up‐regulated in the *ΔugmA* mutant strain revealed several transcription factor binding sites to be overrepresented, including binding sites for the RlmA, MsnA, PacC and SteA transcription factors. The *ΔugmA/ΔrlmA* and *ΔugmA/ΔmsnA* double mutants showed severe synthetic growth defects, indicating that RlmA and MsnA play an important role in survival of the *ΔugmA* mutant. By aligning the new results obtained in this study to previous cell wall stress related transcriptomic studies in *A. niger*, a better understanding of the transcriptional response of the CWI signalling response is obtained which serves as a solid basis for comparing both differences and similarities in relation to CWI signalling in filamentous fungi.

Results {#cmi12624-sec-0011}
=======

*Constitutive phosphorylation of CWI‐MAPK in the* ΔugmA *mutant of* A. niger {#cmi12624-sec-0012}
----------------------------------------------------------------------------

The *ΔugmA* mutant of *A. niger* was isolated in a screen for cell wall mutants by selecting for mutants with induced expression of *agsA.* Targeted deletion of the *ugmA* gene confirmed its importance for CWI (Damveld *et al.,* [2008](#cmi12624-bib-0010){ref-type="ref"}). In subsequent studies, we showed that the *ΔugmA* mutant does not contain Gal*f*‐containing glycostructures in the cell wall (galactomannan) or the medium (galactomannoproteins) (Park *et al.,* [2014](#cmi12624-bib-0036){ref-type="ref"}; Park *et al.,* [2015](#cmi12624-bib-0037){ref-type="ref"}). Because the induction of *agsA* in response to Calcofluor White induced cell wall stress is RlmA dependent (Damveld *et al.,* [2005a](#cmi12624-bib-0008){ref-type="ref"}) it was previously suggested that the transcriptomic responses in the *ugmA* mutant were mediated via the CWI pathway (Damveld *et al.,* [2008](#cmi12624-bib-0010){ref-type="ref"}). To establish the role of the CWI pathway in cell wall remodelling in the *ΔugmA* mutant more firmly, the phosphorylation state of the CWI‐related MAP kinase (CWI‐MpkA) was evaluated. Therefore, proteins extracts were prepared from wild‐type and *ΔugmA* strains and analysed by Western blot using anti‐phospho p44/42. The total amount of MpkA was detected by using the anti p44/42 MAPK antibody. As shown in Fig. [1](#cmi12624-fig-0001){ref-type="fig"}, the MAP kinase in the Δ*ugmA* mutant displays at various time points during growth a consistent higher phosphorylation status compared the wild‐type strain. Quantification of the signal indicates a threefold higher level of phosphorylation (Fig. [1](#cmi12624-fig-0001){ref-type="fig"}). These results indicate that loss of galactofuranose biosynthesis signals via MpkA phosphorylation in the *A*. *niger* CWI pathway.

![The *ΔugmA* mutant strain has increased and constitutive CWI pathway activation. Conidia from the wild‐type and mutant strain were grown in liquid CM medium. The samples were collected at the indicated time points for Western blot preparation. The phosphorylated fractions and the total MpkA amount were detected using anti‐phospho p44/42 MAPK and anti‐p44/42 MAPK antibodies respectively. The γ‐tubulin antibody and the Coomassie Brilliant Blue stained gel were used as loading sample controls. Densitometry analysis of western blots showing the ratio of phosphorylated MpkA/MpkA expressed as the relative abundance (arbitrary units).](CMI-18-1268-g001){#cmi12624-fig-0001}

*Growth analysis of the* ΔugmA *mutant of* A. niger {#cmi12624-sec-0013}
---------------------------------------------------

To perform genome‐wide expression analysis of the *ΔugmA* mutant, we initially cultivated it in a bioreactor under conditions normally used for wild‐type *A. niger* batch cultivations (Jørgensen *et al.,* [2010](#cmi12624-bib-0028){ref-type="ref"}; Nitsche *et al.,* [2012a](#cmi12624-bib-0032){ref-type="ref"}, [2012b](#cmi12624-bib-0033){ref-type="ref"}). According to this standard growth protocol, the pH of the cultivations is set at pH 3.0 during spore germination and kept constant during the exponential and post‐exponential growth phases. Starting the cultivation at pH 3.0 prevents aggregation of the conidiospores and thereby prevents pellet formation. The pH is normally kept continuously at 3.0, which is close to the normal ambient pH created by *A. niger* through the secretion of acids. However, we noticed very poor growth of the *ΔugmA* at pH 3.0 (Table [1](#cmi12624-tbl-0001){ref-type="table-wrap"}) compared to the wild‐type strain (N402) and therefore also examined growth of the *ΔugmA* mutant at other pH values. In the bioreactor cultures run at pH 4.0, pH 5.0 and pH 6.0 were started at pH 3.0 to prevent spore aggregation and the pH was set to the desired pH after germination of the spores which takes about 5 h. The maximum growth rate of the *ΔugmA* was strongly improved at pH 4.0 and 5.0, but still slightly lower than in the wild‐type (Table [1](#cmi12624-tbl-0001){ref-type="table-wrap"}). At pH 6.0, the maximum growth rates of both the wild‐type and the *ΔugmA* mutant were significantly lower (Table [1](#cmi12624-tbl-0001){ref-type="table-wrap"}). The morphology of the *ΔugmA* mutant was still aberrant at pH 5.0 compared to the wild‐type strain and characterized by short hyphal fragments and increased branching (Fig. [2](#cmi12624-fig-0002){ref-type="fig"}A). At all pH conditions, the *ΔugmA* mutant did not produce any Gal*f*‐containing glycostructures in the culture medium, whereas Gal*f* was present in the culture medium of the wild‐type strain (Fig. [2](#cmi12624-fig-0002){ref-type="fig"}B shows data for pH 5.0; data obtained at the other pHs not shown).

###### 

Growth characteristics of the wild‐type (N402) and the *ΔugmA* mutant in pH‐controlled bioreactors.

        N402          *ΔugmA*                     
  ----- ------------- ------------- ------------- -------------
  3.0   0.22 ± 0.02   4.81 ± 0.53   0.04          2.43
  4.0   0.23          3.79          0.20          4.24
  5.0   0.25 ± 0.04   3.37 ± 0.02   0.20 ± 0      3.45 ± 0.01
  6.0   0.14 ± 0.01   1.28 ± 0.18   0.11 ± 0.01   1.57 ± 0.05

The averages and standard deviations of the growth rate are based on independent bioreactor cultivations.

![Cultivation of the wild‐type (N402) and the *ΔugmA* mutant in bioreactors.\
A. Hyphal morphology of N402 and *ΔugmA* mutant. Note the compact growth phenotype of the *ΔugmA* mutant.\
B. Dot blot assay to detect the presence of Gal*f* residues on secreted glycoconjugates from *A. niger* during batch growth. *A. niger* wild‐type strain (N402) and *ΔugmA* mutant were grown for the times indicated from inoculation of the spores, and cell‐free medium was spotted on nitrocellulose filter paper. The blots were incubated with the anti‐Gal*f* antibody (L10) (Heesemann *et al.,* [2011](#cmi12624-bib-0026){ref-type="ref"}) to detect the presence of Gal*f* or incubated with ConA‐PO to detect mannoproteins.](CMI-18-1268-g002){#cmi12624-fig-0002}

*Comparison of the transcriptome of the* ΔugmA *mutant with the wild‐type strain* {#cmi12624-sec-0014}
---------------------------------------------------------------------------------

To identify genes in *A. niger* that are differentially expressed in the *ΔugmA* mutant compared to the wild‐type strain, RNA was extracted from mycelium of the wild‐type (N402) and the *ΔugmA* mutant after growth at pH 5. The maximum growth rate of the *ΔugmA* strain (0.20 h^−1^) was slightly lower than the growth rate of the wild‐type strain (0.25 h^−1^). Biomass accumulation profiles of the wild‐type (N402) and *ΔugmA* mutant at pH 5 were reproducible (Table [1](#cmi12624-tbl-0001){ref-type="table-wrap"}) and mycelium for RNA extraction was harvested when 60% of the maximum biomass was reached. The RNA samples were analysed by Northern blot to examine whether marker genes known or expected to be induced in the *ΔugmA* mutant were up‐regulated. As the *ΔugmA* mutant was identified in a screen for mutants with induced expression of an *agsA*‐driven reporter gene (Damveld *et al.,* [2008](#cmi12624-bib-0010){ref-type="ref"}), we expected the *agsA* gene to be higher expressed in the *ΔugmA*. As shown in Fig. [3](#cmi12624-fig-0003){ref-type="fig"}, the *agsA* gene was indeed strongly induced in the *ΔugmA* mutant compared to the wild‐type strain. We also tested the expression of three other genes (*gfaA*: glutamine:fructose‐6‐phosphate amidotransferase, which is responsible for the first step in chitin synthesis) and two genes encoding putative cell wall proteins (PhiA and PirA), which were previously shown to be induced by cell wall stress (Ram *et al.,* [2004](#cmi12624-bib-0042){ref-type="ref"}; Meyer *et al.,* [2007](#cmi12624-bib-0031){ref-type="ref"}). These genes were also clearly induced in the *ΔugmA* mutant indicating that a typical cell wall stress response was activated in the *ΔugmA* mutant (Fig. [3](#cmi12624-fig-0003){ref-type="fig"}).

![Northern blot analysis of selected genes during batch growth in bioreactors. RNA was isolated from mycelium grown at pH 5.0 for 18 h, when about 60% of the glucose was consumed, and analysed by Northern blot. Hybridization with an actin probe was used to confirm similar loading.](CMI-18-1268-g003){#cmi12624-fig-0003}

Genome‐wide expression analysis using RNA‐seq revealed in total 741 genes that were differentially expressed between the wild‐type and the *ΔugmA* mutant. Differential expression was defined as a statistically significant, differential expression with a false discovery rate (FDR) \<0.05. In total, 432 genes were relatively higher expressed in the *ΔugmA* mutant, and we will refer to these genes as UgmA^up^ and 309 genes were relatively lower expressed in the *ΔugmA* mutant (UgmA^down^). The normalized expression values for the genes monitored by Northern blot are shown in Fig. [3](#cmi12624-fig-0003){ref-type="fig"} and agree well with the Northern blot results. A comprehensive list of all differentially expressed genes including statistical significance and transcript ratios is presented in [Table S1](#cmi12624-supitem-0001){ref-type="supplementary-material"} (UgmA^up^) and [Table S2](#cmi12624-supitem-0001){ref-type="supplementary-material"} (UgmA^down^).

To get a better insight into the processes that are affected in the *ΔugmA* mutant, we performed GO‐enrichment analysis of the genes that were significantly higher expressed in the *ΔugmA* mutant using FetGOat (Nitsche *et al.,* [2012a](#cmi12624-bib-0032){ref-type="ref"}, [2012b](#cmi12624-bib-0033){ref-type="ref"}) (Tables [2](#cmi12624-tbl-0002){ref-type="table-wrap"} and [3](#cmi12624-tbl-0003){ref-type="table-wrap"}). Twenty‐one GO terms (Biological Processes) were overrepresented in the *ΔugmA* mutant ([Table S3](#cmi12624-supitem-0001){ref-type="supplementary-material"}). Among those GO terms, six terminal nodes were present (Table [2](#cmi12624-tbl-0002){ref-type="table-wrap"}). GO enrichment analysis of the genes down‐regulated in the *ΔugmA* mutant identified three GO terms that were related to zinc metabolism ([Table S4](#cmi12624-supitem-0001){ref-type="supplementary-material"}). The three genes in the terminal node (GO:0071577; zinc ion transmembrane transport) (Table [3](#cmi12624-tbl-0003){ref-type="table-wrap"}) all encode putative zinc transporters, suggesting a lower need for zinc in the *ΔugmA* mutant. Closer examination of the genes and GO terms upregulated and enriched in the *ΔugmA* mutant revealed two groups of overrepresented genes. The first group of genes encodes proteins related to chitin biosynthesis and included genes encoding proteins involved in UDP‐N‐acetyl‐glucosamine biosynthesis (*gnaA, gfaA* and *gfaB*) as well as chitin polymerization (*chsA* and *chsB*) (Table [4](#cmi12624-tbl-0004){ref-type="table-wrap"}). The second group encodes glycosyl hydrolases (GH) and includes genes encoding proteins that act on the plant cell wall polysaccharides cellulose, xylan and galactan. In total, 18 plant cell wall degradation genes were highly expressed in the *ΔugmA* mutant. (See below)

###### 

Enriched GO‐terms in the up‐regulated genes in the *ΔugmA* strain.

  Terminal GO term   Description GO term                             Systematic name   Gene name   Description
  ------------------ ----------------------------------------------- ----------------- ----------- ------------------------------------------------------------------------------------------------------------------------------
  GO:0045490         Pectin catabolic processes                      An14g04200        *rhgB*      Rhamnogalacturonan hydrolase
                                                                     An01g11520        *pgaI*      Polygalacturonase
                                                                     An04g09690                    Putative pectin methylesterase
                                                                     An16g02730                    Putative arabinan endo‐1,5‐alpha‐L‐arabinosidase
                                                                     An02g10550        *abnC*      Putative endo‐alpha‐1,5‐arabinanase
  GO:0006031         Chitin biosynthetic processes                   An09g04010        *chsB*      Putative chitin synthase, class III; induced by caspofungin
                                                                     An03g05940        *gfaB*      Putative glutamine:fructose‐6‐phosphate amidotransferase
                                                                     An07g05570        *chsA*      Chitin synthase class I
                                                                     An12g07840        *gnaA*      Putative glucosamine‐6‐phosphate N‐acetyltransferase
                                                                     An18g06820        *gfaA*      Putative glutamine:fructose‐6‐phosphate amidotransferase
  GO:0005996         Monosaccharide metabolic processes              An01g11520        *pgaI*      Polygalacturonase
                                                                     An02g10550        *abnC*      Putative endo‐alpha‐1,5‐arabinanase
                                                                     An14g04200        *rhgB*      Rhamnogalacturonan hydrolase
                                                                     An03g00960        *axhA*      1,4‐Beta‐D‐arabinoxylan arabinofuranohydrolase
                                                                     An14g01800                    Putative alpha‐galactosidase
                                                                     An04g02670                    Predicted oxidoreductase activity
                                                                     An09g02240        *nag1*      N‐Acetyl‐beta‐glucosaminidase
                                                                     An02g11150        *aglB*      Putative alpha‐galactosidase variant B
                                                                     An01g12550        *msdS*      Mannosyl‐oligosaccharide 1,2‐alpha‐mannosidase
                                                                     An04g03200                    Mannose‐6‐phosphate isomerase
                                                                     An01g00780        *xynB*      Endo‐1,4‐xylanase
                                                                     An12g07840        *gnaA*      Putative glucosamine‐6‐phosphate N‐acetyltransferase
  GO:0010383         Cell wall polysaccharide metabolic processes    An14g02760        *eglA*      Putative secreted endoglucanase A; xylose‐induced
                                                                     An02g11150        *aglB*      Putative alpha‐galactosidase variant B; expression is induced on xylan
                                                                     An18g06820        *gfaA*      Putative glutamine:fructose‐6‐phosphate amidotransferase
                                                                     An03g05940        *gfaB*      Putative glutamine:fructose‐6‐phosphate amidotransferase
                                                                     An01g00780        *xynB*      Endo‐1,4‐xylanase
                                                                     An14g01800                    Putative alpha‐galactosidase
  GO:0009251         Glucan metabolic processes                      An02g00850                    Glucoamylase (exo‐1,4‐glucosidase/amyloglucosidase); beta‐glucanase
                                                                     An16g06800        *eglB*      Putative endoglucanase
                                                                     An15g04900                    Putative endo‐glucanase
                                                                     An03g05290        *bgtB*      Glucan 1,3‐beta‐glucosidase; putative glucanotransferase (caspofungin induced)
                                                                     An07g08950        *eglC*      Endoglucanase; specific for substrates with beta‐1,3 and beta (XlnR controlled)
  GO:0070882         Cellular cell wall organization or biogenesis   An05g00340                    Unknown function, Has domain(s) with predicted hydrolase
                                                                     An14g02760        *eglA*      Putative secreted endoglucanase A; abundantly expressed on D‐xylose; irreversibly inhibited by palladium ion; XlnR regulated
                                                                     An10g00430                    Strong similarity to agglutinin core protein Aga1
                                                                     An08g03510                    Serine‐rich protein
                                                                     An06g01900                    Similarity to polyphosphoinositide binding protein Ssh2p
                                                                     An07g05570        *chsA*      Chitin synthase class I
                                                                     An14g01800                    putative Alpha‐galactosidase
                                                                     An02g07670                    Serine‐rich protein
                                                                     An02g11150        *aglB*      Putative alpha‐galactosidase variant B; expression is induced on xylan; XlnR regulated
                                                                     An18g06820        *gfaA*      Putative glutamine:fructose‐6‐phosphate amidotransferase (CA‐induced)
                                                                     An03g05940        *gfaB*      Putative glutamine:fructose‐6‐phosphate amidotransferase (CA‐induced)
                                                                     An01g09050                    Ortholog(s) have FAD transmembrane transporter activity

###### 

Enriched GO‐term in genes downregulated in the *ΔugmA* strain.

  Terminal GO term   Description GO term                Systematic name   Gene name   Description
  ------------------ ---------------------------------- ----------------- ----------- --------------------------------------------------------------
  GO:0071577         Zinc ion transmembrane transport   An01g01620                    Putative high‐affinity zinc uptake transmembrane transporter
                                                        An12g10320        *zrtA*      Putative high‐affinity zinc transport protein
                                                        An01g06690                    Putative low‐affinity zinc ion transmembrane transporter

###### 

Differentially expressed cell wall modifying genes (FC \> 1.3; FDR \< 0.05).

  Upregulated genes                                                                                                    Normalized expression value                                           
  --------------------- ------------------------------------------------------------------------------------- -------- ----------------------------- -------- ------- ------- ------ --- --- ---
  An10g00400            Putative 1,3‐beta‐glucanosyltransferase GH72;                                         *gelA*   335.5                         637.5    0.93    0.028   up     n   y   y
  An16g06120            Putative 1,3‐beta‐glucanosyltransferase GH72                                          *gelF*   1.6                           47.2     4.91    0.001   up     n   n   n
  An02g09050            Putative 1,3‐beta‐glucanosyltransferase GH72                                          *gelG*   2.2                           5.4      1.30    0.035   up     n   y   y
  An03g05290            Putative beta‐1,3‐glucanosyltransferase GH17                                          *bgtB*   668.5                         1601.5   1.26    0.013   up     y   y   y
  An13g02510            Putative transglycosidase of GH16‐family ScCrh1                                       *crhE*   1.5                           11.4     2.91    0.001   up     n   y   n
  An01g12450            Putative exo‐beta‐1,3‐glucanase GH55‐family                                           *bxgA*   73.2                          193.5    1.40    0.001   up     n   y   n
                                                                                                                                                                                             
  Alpha‐glucan                                                                                                                                                                               
  An04g09890            Putative alpha1,3‐glucan synthase                                                     *agsA*   1.2                           49.0     5.34    0.001   up     y   y   n
  An08g09610            Putative alpha‐1,3‐glucanase GH71                                                     *agnD*   51.8                          91.8     0.82    0.035   up     n   y   y
                                                                                                                                                                                             
  Chitin                                                                                                                                                                                     
  An09g04010            Putative chitin synthase class‐III                                                    *chsB*   144.3                         282.8    0.97    0.016   up     n   y   n
  An12g10380            Putative chitin synthase class‐III                                                    *chsE*   80.8                          160.3    0.99    0.007   up     y   y   n
  An07g05570            Putative chitin synthase class‐II                                                     *chsA*   20.5                          42.5     1.05    0.001   up     n   y   y
  An04g04670            Putative class‐V chitinase (GH18)                                                     *cfcC*   36.8                          72.4     0.98    0.006   up     y   y   y
                                                                                                                                                                                             
  Galactomannan                                                                                                                                                                              
  An02g08670            UDP‐galactofuranose transporter                                                       *ugtA*   245.9                         456.4    0.89    0.035   up     y   n   n
  An12g08720            UDP‐galactofuranose transferase                                                       *gfsA*   98.0                          203.7    1.06    0.002   up     y   y   n
                                                                                                                                                                                             
  CWP‐linking                                                                                                                                                                                
  An14g03520            Putative endo‐mannanase (GH76‐family) with a possible role in GPI‐CWP incorporation   *dfgC*   42.0                          107.8    1.36    0.001   up     y   y   n
                                                                                                                                                                                             
  Downregulated genes                                                                                                                                                                        
  beta‐1,3‐glucan                                                                                                                                                                            
  An19g00090            Putative exo‐beta‐1,3‐glucanase GH55‐family                                           *bgxC*   2.9                           1.0      −1.55   0.011   down   n   n   n
                                                                                                                                                                                             
  Chitin                                                                                                                                                                                     
  An09g06400            Putative class‐III chitinase (GH18)                                                   *ctcA*   255.7                         2.2      −6.86   0.001   down   n   n   n
                                                                                                                                                                                             
  Galactomannan                                                                                                                                                                              
  An02g11320            UDP‐glucose 4‐epimerase                                                               *ugeC*   72.6                          33.0     −1.14   0.002   down   n   n   n
  An02g08660            UDP‐galactose mutase                                                                  *ugmA*   167.8                         5.5      −4.93   0.001   down   n   n   n
                                                                                                                                                                                             
  CWP‐linking                                                                                                                                                                                
  An11g01240            Putative endo‐mannanase (GH76‐family) with a possible role in GPI‐CWP incorporation   *dfgH*   10.2                          4.1      −1.31   0.022   down   n   n   n

Consensus bindings sites for RlmA (TAWWWWTAG), MsnA (AGGGG) and CrzA (GWGGCS) were used.

*Cell wall remodelling in the* ΔugmA *mutant* {#cmi12624-sec-0015}
---------------------------------------------

Table [4](#cmi12624-tbl-0004){ref-type="table-wrap"} lists the differential expression of the genes directly involved in the biosynthesis of the cell wall polysaccharides β‐glucan, α‐glucan, chitin and galactomannan (Pel *et al.,* [2007](#cmi12624-bib-0040){ref-type="ref"}). In addition to *agsA* and genes involved in UDP‐N‐acetyl‐glucosamine biosynthesis (*gnaA*, *gfaA* and *gfaB*), differentially expressed genes include genes encoding proteins involved in chitin polymerization (*chsA* and *chsB*), a putative 1,3‐β‐glucanosyltransferase *gelF* and a gene encoding a putative glucan‐chitin cross‐linking enzyme (*crhE*). Although several chitin synthase‐encoding genes showed a statistically significant induction, their fold‐changes were limited, varying between 1.5 and 2. The strongest down‐regulated gene in the *ΔugmA* mutants compared to wild‐type is a chitinase (*ctcA*)‐encoding gene showing a \>100‐fold decrease in expression (Table [4](#cmi12624-tbl-0004){ref-type="table-wrap"}).

The genome of *A. niger* is predicted to contain 117 glycosylphosphatidylinositol (GPI)‐anchored proteins (Pel *et al.,* [2007](#cmi12624-bib-0040){ref-type="ref"}). GPI‐anchored proteins can either remain attached to the plasma membrane (mostly cell wall biosynthetic enzymes) or can become covalently linked to the β‐glucan part of the cell wall (Frieman and Cormack, [2003](#cmi12624-bib-0020){ref-type="ref"}, [2004](#cmi12624-bib-0021){ref-type="ref"}). Table [5](#cmi12624-tbl-0005){ref-type="table-wrap"} summarizes the differentially expressed, putative GPI‐anchored protein‐encoding genes. Expression of 17 GPI‐anchored protein‐encoding genes was up‐regulated in the *ΔugmA* and 16 was down‐regulated, suggesting important changes in the composition of membrane‐ and cell wall‐localized GPI‐anchored proteins. The set of down‐regulated genes also includes the gene encoding CwpA, which is currently the only cell wall protein from *A. niger* for which a covalent linkage to the cell wall has been experimentally confirmed (Damveld *et al.,* [2005a](#cmi12624-bib-0008){ref-type="ref"}, [2005b](#cmi12624-bib-0009){ref-type="ref"}, [2005c](#cmi12624-bib-0011){ref-type="ref"}).

###### 

Differentially expressed genes encoding putative (GPI)‐anchored cell wall proteins[\*](#cmi12624-note-0003){ref-type="fn"}.

                                                                                                Normalized expression value                                    
  --------------- ------------------------------------------------------------------- --------- ----------------------------- -------- ------- ------- --- --- ---
  An01g12240      Unknown function                                                              4.2                           385.3    6.54    0.001   y   n   y
  An02g00850      Putative glucanase related to MLG1 ‐ *Neurospora crassa*                      4.7                           57.0     3.61    0.001   y   n   y
  An03g02510      Unknown function                                                              0.92                          2.9      1.66    0.046   n   y   n
  An03g05530      Putative endo‐beta‐1.4‐glucanase                                              16.9                          54.0     1.68    0.001   y   y   n
  An03g05620      Putative hydrolases or acyltransferases                                       1.0                           9.1      3.19    0.002   n   n   n
  An04g07160      Unknown function                                                              52.7                          162.9    1.63    0.001   n   y   n
  An09g03260      Endo‐polygalacturonase D                                            *pgaD*    1.5                           4.3      1.57    0.032   n   y   y
  An10g00390      Putative cellobiose dehydrogenase CDH                                         2.9                           11.8     2.05    0.001   n   y   n
  An12g07430      Putative dioxygenase C                                                        4.2                           32.2     2.95    0.001   n   y   n
  An13g02670      Unknown function                                                              0.6                           183.2    8.27    0.001   n   y   n
  An14g01068      Unknown function                                                              112.1                         275.2    1.30    0.001   y   y   y
  An14g01820      Cell wall protein binB                                                        2.6                           378.6    7.17    0.001   y   y   y
  An14g01840      Temperature‐shock induced protein Tir3                                        107.8                         719.7    2.74    0.002   n   n   y
  An14g02170      Putative cutinase                                                             0.26                          2.0      2.97    0.123   n   n   n
  An15g07790      Unknown function                                                              n.d.                          1.3      inf     0.001   y   y   y
  An18g03730      Unknown function                                                              507.6                         3073.2   2.60    0.001   n   y   y
                                                                                                                                                               
  Downregulated                                                                                                                                                
  An02g09010      Unknown function                                                              7.6                           2.7      −1.47   0.007   n   n   n
  An02g13220      Putative lysophospholipase phospholipase                                      397.4                         156.5    −1.34   0.001   n   n   n
  An07g04620      *N. crassa* Ham7 required for cell fusion.                          *ham‐7*   136.8                         13.4     −3.35   0.001   n   n   n
  An07g06210      Unknown function                                                              45.9                          19.1     −1.27   0.003   n   n   n
  An08g07090      Similarity to protein Sim1                                                    105.0                         43.7     −1.27   0.001   n   n   n
  An08g09850      Putative phosphatase precursor                                                3.5                           0.9      −2.01   0.013   n   n   n
  An09g02340      Similarity to self‐pruning protein SP ‐ *Lycopersicon esculentum*             76.4                          26.1     −1.55   0.001   n   n   n
  An12g07750      Unknown function                                                              78.9                          23.1     −1.77   0.001   n   n   n
  An13g02130      Putative aspartyl protease;                                                   12.0                          2.6      −2.22   0.001   n   n   n
  An14g02100      Cell wall protein A (CwpA) *Aspergillus niger*                      *cwpA*    65.9                          1.2      −5.77   0.001   n   n   n
  An16g01780      Unknown function                                                              94.8                          45.6     −1.06   0.002   n   n   n
  An16g07920      Unknown function                                                              165.4                         46.8     −1.82   0.001   n   n   n
  An16g07950      Unknown function                                                              872.5                         359.7    −1.28   0.001   n   n   n
  An18g00630      Unknown function                                                              23.5                          7.9      −1.58   0.004   n   n   n
  An18g01320      Putative aspartyl protease                                                    80.5                          45.0     −0.84   0.037   n   n   n
  An18g04070      Unknown function                                                              1322.2                        230.5    −2.52   0.001   n   n   n
  An18g06360      Similarity to surface antigen Csa1 ‐                                          14.7                          5.6      −1.38   0.035   n   n   n

GPI‐anchored proteins known to be directly involved in cell wall biosynthesis (Table [4](#cmi12624-tbl-0004){ref-type="table-wrap"}) are not included in this table.

The major pathway for cell wall remodelling is the CWI pathway, which has been studied most extensively in *S. cerevisiae.* This pathway comprises among other proteins, the cell wall stress sensors (Wsc‐ and Mid‐proteins), the Rho1 GTPase module, Pkc1 and the Bck1‐Mkk1/Mkk2‐Mpk1 MAP kinase signalling cascade. Activation of the CWI pathway results in activation of the Rlm1 transcription factor, which can bind to a conserved motif in promoter regions of cell wall stress‐induced genes and activate their transcription. Homologs of these proteins have been identified in *Aspergilli* and have been shown to be also involved in the cell wall stress response (Damveld *et al.,* [2005a](#cmi12624-bib-0008){ref-type="ref"}, [2005b](#cmi12624-bib-0009){ref-type="ref"}, [2005c](#cmi12624-bib-0011){ref-type="ref"}; Dichtl *et al.,* [2012](#cmi12624-bib-0012){ref-type="ref"}). From the list of genes related to the CWI pathway of *A. niger* (Pel *et al.,* [2007](#cmi12624-bib-0040){ref-type="ref"}), three genes encoding a putative cell wall stress sensor protein WscC (An07g04070), a small GTPase RhoB (An16g04200) and MkkA (An18g03740) were transcriptionally induced (Table [6](#cmi12624-tbl-0006){ref-type="table-wrap"}). No CWI‐related genes were down‐regulated in the *ΔugmA* strain.

###### 

Upregulated cell wall integrity pathway‐related genes.

                                                                               Normalized expression value                                  
  ------------ ------------------------------------------------------ -------- ----------------------------- ------- ------ ------- --- --- ---
  An07g04070   Putative plasma membrane cell wall sensor              *wscC*   105.5                         310.7   1.56   0.001   n   y   y
  An16g04200   Putative Rho‐related GTPase; ScRho2‐ and SpRho2‐like   *rhoB*   118.8                         255.8   1.11   0.003   y   n   y
  An18g03740   MAPKK with putative function in CWI‐signalling         *mkkA*   44.8                          122.8   1.46   0.001   n   n   n

*Identification of transcription factors important to sustain growth of the* ΔugmA *strain* {#cmi12624-sec-0016}
-------------------------------------------------------------------------------------------

The 432 significantly up‐regulated genes in the *ΔugmA* strain were analysed using the TFBSF tool (Meyer *et al.,* [2009](#cmi12624-bib-0030){ref-type="ref"}). The available 1 kb promoter regions of 419 of the 432 up‐regulated genes were analysed for the presence of binding sites established for 118 fungal transcription factors. The number of genes with these binding sites in the group of 419 induced genes was determined and it was evaluated whether the genes with these binding sites are statistically significant over‐ or under‐represented compared to groups of the same size comprising randomly selected genes of *A. niger* (500 000 bootstrap samples, FDR ≤0.0005) ([Table S5](#cmi12624-supitem-0001){ref-type="supplementary-material"}).

Using this *in silico* approach, four transcription factor binding sites were found to be enriched (Table [7](#cmi12624-tbl-0007){ref-type="table-wrap"}). These are SteA (ScSte12‐homolog), PacC (ScRim101‐homolog), MsnA (ScMsn2/4‐homolog) and RlmA (ScRlm1‐homolog). The identification of the RlmA transcription factor binding site is in agreement with the function of the RlmA transcription factor in the CWI pathway and its requirement for the induction of *agsA* (Damveld *et al.,* [2005a](#cmi12624-bib-0008){ref-type="ref"}, [2005b](#cmi12624-bib-0009){ref-type="ref"}, [2005c](#cmi12624-bib-0011){ref-type="ref"}). A recent study addressing the role of transcription factors in response to cell wall perturbing drugs identified RlmA, MsnA and CrzA transcription factors as being involved in cell wall remodelling in *A. niger* (Fiedler *et al.,* [2014](#cmi12624-bib-0017){ref-type="ref"}). Although CrzA binding sites were not identified as being overrepresented in the *ΔugmA* induced gene set, we decided to include CrzA in our subsequent studies.

###### 

Transcription factor binding site enrichment analysis of *ΔugmA*‐induced genes.

  *S. cerevisiae* transcription factor   *A. niger* ortholog   ReqGN    ReqPG   RanGN    RanPG   *p*‐Value    FDR
  -------------------------------------- --------------------- -------- ------- -------- ------- ------------ ------------
  Rim101p                                PacC                  316.00   75.42   270.08   64.46   2.00E − 06   1.18E − 04
  Ste12p                                 SteA                  229.00   54.65   161.53   38.55   2.00E − 06   1.18E − 04
  Msn2p/Msn4p                            MsnA                  291.00   69.45   246.47   58.82   4.00E − 06   1.57E − 04
  Rlm1p                                  RlmA                  81.00    19.33   51.10    12.20   1.00E − 05   2.95E − 04

ReqGN: number of genes with at least one putative TF binding site in the gene set up‐regulated in the *ΔugmA* mutant.

ReqPG: percent of genes with at least one putative TF binding site in the gene set up‐regulated in the *ΔugmA* mutant.

RanGN: average number of genes with at least one putative TF binding site in random gene sets.

RanPG: average percent of genes with at least one putative TF binding site in random gene sets.

*p*‐Value: probability to get equal/more extreme number of genes with at least one putative TF binding site in random gene sets compared to the gene set up‐regulated in the *ΔugmA* mutant.

FDR: FDR corrected *p*‐value.

To evaluate the importance of the five transcription factors (SteA, PacC, MsnA, RlmA and CrzA) with respect to growth of the *ΔugmA* strain, *ΔugmA*/*ΔTF* double mutants were generated and compared to the growth phenotype of the single mutants. The rationale of this analysis is that if a transcription factor is important for maintaining CWI in the *ΔugmA* mutant, the *ΔugmA*/*ΔTF* double mutant would have a more severe phenotype or even lead to synthetic lethality. As shown in Fig. [4](#cmi12624-fig-0004){ref-type="fig"}, deletion of *ugmA* results in a severe reduction in radial growth and reduced conidiation, as previously observed (Damveld *et al.,* [2008](#cmi12624-bib-0010){ref-type="ref"}). Single deletion of the transcription factors RlmA and SteA did not affect growth on MM. Deletion of the *msnA* gene, resulted in limited growth reduction but the *ΔmsnA* colony still produced spores. Single deletions of *pacC* and *crzA* severely reduced growth, indicative of an important function for these transcription factors during vegetative growth. Somewhat surprisingly the *ΔcrzA* strain grew and sporulated much better at 37 °C compared to growing this mutant at lower temperatures. The strong growth phenotype of the *ΔpacC* and the *ΔcrzA* by itself made it difficult to assess whether their function is specifically required for the *ΔugmA* mutant as it is likely that deletion of *pacC* and *crzA* in the *ΔugmA* mutant will further reduce growth anyway. Analysis of the *ΔugmA/ΔTF* double mutants showed a strong reduction in growth when the *ugmA* deletion was combined with the deletion of the *msnA* or *rlmA* transcription factor. In addition, the growth of the *ΔugmA/ΔcrzA* double mutant at 37 °C also was severely reduced. The synthetic growth defects of the *ΔugmA/ΔrlmA*, *ΔugmA/ΔmsnA* and *ΔugmA/ΔcrzA* double mutant (at 37 °C) suggest that RlmA, MsnA and CrzA target genes are important for survival of the *ΔugmA* mutant. Combining *ΔugmA* with deletion of *ΔsteA* did not show a synthetic growth phenotype indicating that SteA and SteA target genes are not important for survival of the *ΔugmA* mutant. Combining the *ΔugmA* with *ΔpacC* resulted also in very poorly growing colonies, but because single deletion of *pacC* also resulted in poor growth, it is not possible to conclude whether PacC target genes are specifically required for *ΔugmA* survival.

![Growth analysis of single and double mutants. Spores of single and double mutants were spotted in the centre of a MM plate and grown for four days at the indicated temperature. Synergistic growth reduction of the *ΔugmA/msnA* and *ΔugmA/rlmA* is indicative of an important role of the MsnA and RlmA transcription factors in survival of the *ugmA* mutant.](CMI-18-1268-g004){#cmi12624-fig-0004}

Discussion {#cmi12624-sec-0017}
==========

Biosynthesis of Gal*f*‐containing glycoconjugates is important for securing the integrity of the fungal cell wall. Gal*f‐*containing glycoconjugates are found in several ascomycetous clades, including the Eurotiales (*Aspergilli* and *Penicillium* ssp), Sordariales (*Neurospora* and *Magnaporthe* ssp), Hypocreales (*Trichoderma* and *Fusarium* spp), but are absent in the Saccharomycetales (*Saccharomyces* and *Candida* ssp). In the opportunistic pathogen *A. fumigatus*, Gal*f* is an important virulence factor and Gal*f‐*mutants display reduced virulence (Schmalhorst *et al.,* [2008](#cmi12624-bib-0045){ref-type="ref"}). In addition, Gal*f* is an important diagnostic tool to detect early‐stage *A. fumigatus* infections in humans (Alexander and Pfaller, [2006](#cmi12624-bib-0053){ref-type="ref"}). In the past few years the genes encoding the enzymes required for the synthesis of Gal*f*‐containing glycostructures such as galactomannan, *N*‐ and *O*‐glycans, and glycolipids have been identified. Analysis of mutants in genes involved in the biosynthesis of Gal*f* in several Aspergilli has shown that Gal*f*‐mutants have an altered morphology, a different cell wall structure and are in general more susceptible to cell wall synthesis inhibitors as well as cell wall assembly‐disturbing compounds (Damveld *et al.,* [2008](#cmi12624-bib-0010){ref-type="ref"}; Engel *et al.,* [2009](#cmi12624-bib-0014){ref-type="ref"}; Park *et al.,* [2014](#cmi12624-bib-0036){ref-type="ref"}; Afroz *et al*., [2011](#cmi12624-bib-0082){ref-type="ref"}; [2012](#cmi12624-bib-0001){ref-type="ref"}, [2014](#cmi12624-bib-0002){ref-type="ref"}). The genes involved in Gal*f* biosynthesis include *ugeA* (encoding UDP‐glucose‐epimerase), *ugmA* (encoding UDP‐galactose‐mutase), *ugtA* and *ugtB* (encoding a UDP‐Gal*f* transporters) and *gfsA* (encoding a galactofuranosyltransferase) (Komachi *et al*., [2013](#cmi12624-bib-0061){ref-type="ref"}). Genes encoding these enzymes have been characterized in the three best studied *Aspergillus* species (*A. fumigatus*, *A. nidulans* and *A. niger*). In *A. niger*, the biosynthesis of Gal*f* has also been largely elucidated. By performing a genetic screen for cell wall mutants both the *ugeA* and *ugmA* genes have been identified (Damveld *et al.,* [2008](#cmi12624-bib-0010){ref-type="ref"}; Park *et al.,* [2014](#cmi12624-bib-0036){ref-type="ref"}). Because of genetic redundancy of the UDP‐Gal*f* transporters and UDP‐Gal*f* transferases in *A. niger* these genes were not identified in the genetic screen, but simultaneous disruption of the two redundant UDP‐Gal*f* transporters (UgtA and UgtB) and simultaneous disruption of the three putative UDP‐Gal*f* transferases lead to similar phenotypes as the *ΔugeA* and *ΔugmA* mutants (Park *et al.,* [2015](#cmi12624-bib-0037){ref-type="ref"}; Arentshorst *et al*., [2015](#cmi12624-bib-0003){ref-type="ref"}). In addition to increased α‐glucan synthesis and, presumably, α‐glucan levels, *ΔugmA* mutants have increased chitin levels (Afroz *et al*., [2011](#cmi12624-bib-0082){ref-type="ref"}) and show increased expression of *gfaA and gfaB* (Fig. [3](#cmi12624-fig-0003){ref-type="fig"} and Table [4](#cmi12624-tbl-0004){ref-type="table-wrap"}), which both encode glutamine:fructose‐6‐phosphate amidotransferases and are required for the biosynthesis of UDP‐*N*‐acetylglucosamine, the precursor of chitin. These observations indicated that the absence of Gal*f*‐biosynthesis induces a cell wall remodelling programme to counteract the loss of Gal*f*‐containing glycostructures.

In addition to cell wall remodelling enzymes, a group of 18 differentially expressed genes in the *ΔugmA* strain was identified which encode glycosyl hydrolases (GH) that act on the plant cell wall polysaccharides cellulose, xylan and galactan (Table [8](#cmi12624-tbl-0008){ref-type="table-wrap"}). Several of these genes (*xynB*, *eglB*, *eglC*, *aglB*) are known to be controlled by the XlnR transcription factor (van Peij *et al.,* [1998b](#cmi12624-bib-0039){ref-type="ref"}). XlnR encodes a Zn(II)~2~Cys~6~ transcription factor that positively regulates the expression of genes involved in xylose metabolism (van Peij *et al.,* [1998a](#cmi12624-bib-0038){ref-type="ref"}, [1998b](#cmi12624-bib-0039){ref-type="ref"}). Although the mechanism underlying the induced expression of plant cell wall‐degrading enzymes in the *ΔugmA* mutant is unknown, it could be related to a possible accumulation of UDP‐galactose as the pathway to UDP‐Gal*f* is blocked by the absence of UgmA. Accumulation of UDP‐galactose (in the pyranose form) could have an effect on the intracellular galactoglycome, which has been shown to be linked to the production of plant cell wall‐degrading enzymes (Karaffa *et al.,* [2013](#cmi12624-bib-0029){ref-type="ref"}).

###### 

Differentially expressed genes encoding plant cell wall‐degrading enzymes.

               Description                                  Gene name   N402   *ΔugmA*   log~2~ FC   Q‐value   XlnR site^\*^
  ------------ -------------------------------------------- ----------- ------ --------- ----------- --------- ---------------
  An02g00730   Similarity cutinase A gene                               0      37.8      inf         0.001     Y (2x)
  An03g00960   Arabinofuranosidase active on arabinoxylan   *axhA*      0.7    60.3      6.4         0.001     Y (3x)
  An15g07760   Putative beta‐mannanase                                  0.7    32.4      5.6         0.001     Y (2x)
  An02g10550   Endo‐alpha‐1,5‐arabinanase                   *abnA*      2.1    78.5      5.2         0.001     Y (3x)
  An15g04550   Xylanase A                                   *xynA*      18.2   323.5     4.2         0.001     Y (4x)
  An15g04570   Putative endo‐glucanase IV                               8.5    112.7     3.7         0.001     Y (2x)
  An14g04200   Rhamnogalacturonase                          *rhgB*      6.3    69.6      3.5         0.001     Y (2x)
  An15g04900   Putative endoglucanase IV                                3.9    40.6      3.4         0.001     Y (6x)
  An08g05230   Putative endoglucanase IV                                8.4    86.7      3.4         0.001     Y (1x)
  An06g02070   Rhamnogalacturonase rhgA ‐                   *rhgA*      0.8    8.4       3.4         0.001     Y (1x)
  An14g02670   Putative endoglucanase IV                                3.6    31.1      3.1         0.001     Y (2x)
  An04g09690   Pectin methylesterase                        *pme1*      0.7    5.6       3.0         0.001     Y (6x)
  An01g00780   Xylanase B                                   *xynB*      35.3   241.7     2.8         0.001     Y (6x)
  An14g01800   Putative alpha‐galactosidase                             0.6    3.2       2.5         0.014     Y (1x)
  An13g03140   Putative endo‐beta‐1,4‐glucanase                         2.8    13.4      2.2         0.001     N
  An09g03260   Endo‐polygalacturonase D^\*^                 *pgaD*      1.5    4.3       1.6         0.03      Y (4x)
  An02g11150   Alpha‐galactosidase                          *aglB*      60.3   141.8     1.2         0.04      Y (2x)
  An16g02730   Endo‐1,5‐alpha‐arabinase                     *abnA*      42.3   91.6      1.1         0.003     Y (2x)

Consensus binding sites for XlnR (GGCTRR or GGNTAAA)

We previously studied the genome‐wide cell wall stress response in *A. niger* by challenging germlings with antifungals affecting cell wall synthesis or assembly. These treatments include the exposure to the β‐1,3‐glucan synthase inhibitor CA and the ergosterol biosynthesis inhibitor FP (Meyer *et al.,* [2007](#cmi12624-bib-0031){ref-type="ref"}) as well as exposure to sphingolipid inhibitor aureobasidin A (AbaA), and calcineurin inhibitor FK506 (Fiedler *et al.,* [2014](#cmi12624-bib-0017){ref-type="ref"}). Compound‐induced genes in these studies were defined based on a FDR \< 0.05 and resulted in 134 differentially expressed genes for CA, 178 for AbaA, 22 for FP and 49 for FK506 (Fiedler *et al.,* [2014](#cmi12624-bib-0017){ref-type="ref"}; [Table S6](#cmi12624-supitem-0001){ref-type="supplementary-material"}). We were interested whether the sets of genes up‐regulated in the *ΔugmA* mutant showed overlap with the gene sets up‐regulated by the various treatments. As shown in Fig. [5](#cmi12624-fig-0005){ref-type="fig"}, the largest overlap of the 432 genes up‐regulated in the *ΔugmA* mutant was observed with the CA‐induced gene set (35 genes overlapping) and AbaA (33 genes overlapping) (Fig. [5](#cmi12624-fig-0005){ref-type="fig"}). No overlapping genes were identified between the *ΔugmA*‐induced genes and FP‐ or FK506‐treated germlings (data not shown). The gene identities for the different groups of genes are given in [Table S6](#cmi12624-supitem-0001){ref-type="supplementary-material"}. The numbers also show that there is only a limited overlap of genes that are commonly induced. In fact, when comparing CA‐induced, AbaA‐induced and *ΔugmA*‐induced gene expression nine genes were commonly induced (Table [9](#cmi12624-tbl-0009){ref-type="table-wrap"}). The majority of these nine genes encode proteins with unknown functions. Two proteins An04g03870 and An06g01900 encode homologs of the *S. cerevisiae* Dpp1p and Csr1p proteins. Dpp1p is a diacylglycerol diphosphate phosphatase, which synthesizes the second messenger diacylglycerol, a potential activator of protein kinase C of the CWI signalling cascade. Csr1p is a phosphatidylinositol transfer protein belonging to the Sec14‐family, which has a potential role in regulating lipid and fatty acid metabolism and indicates turnover of phosphoinositides in response to different forms of cell wall stress, possibly, to relocate proteins involved in CWI signalling, such as Wsc1p, Rho1p, Rom2p and Pkc1p to the proper location at the membrane (Fernández‐Acero *et al.,* [2015](#cmi12624-bib-0016){ref-type="ref"}). The limited overlap of genes between the various treatments could have multiple reasons and might relate to the fact that treatments with antifungals provoke both short‐term and transient responses, while the *ΔugmA* mutant is fully adapted to the lack of Gal*f* biosynthesis and therefore represents a long‐term adaptation. Alternatively, a noticeable difference between the *ΔugmA* transcriptome (this study) and transcriptome in response to chemical compounds (previous studies) is that the *ugmA* study was performed with mycelia while the chemical compound studies were performed with germlings. The limited overlap could also be well related to differences between the expression of cell wall biosynthetic genes during spore germination and vegetative growth.

![Overview of the number of genes overlapping between different cell wall stress conditions. Caspofungin (CA)‐induced genes (Meyer *et al.,* [2007](#cmi12624-bib-0031){ref-type="ref"}) and Aureobasidin A (AbaA)‐induced genes (Fiedler *et al.,* [2014](#cmi12624-bib-0017){ref-type="ref"}) were compared to *ΔugmA*‐induced genes (this study).](CMI-18-1268-g005){#cmi12624-fig-0005}

###### 

Description of commonly induced genes after CA or AbaA treatments and in the *ΔugmA* mutant.

  Gene\#       Description[\*](#cmi12624-note-0010){ref-type="fn"}                                                 *S. cerevisiae* homolog
  ------------ --------------------------------------------------------------------------------------------------- -------------------------
  An04g03870   Diacylglycerol diphosphate phosphatase activity                                                     Ddp1
  An05g00760   Protein with unknown function                                                                       
  An06g01900   Sec14 family; member phosphatidylinositol transfer protein                                          Csr1
  An07g05820   Protein with unknown function                                                                       
  An12g06380   Protein of unknown function, highly repetitive; ortholog in *A. fumigatus* is farnesol‐responsive   
  An14g01070   Protein with unknown function                                                                       
  An14g01840   GPI anchored protein; strongly induced in *ugmA*                                                    
  An15g07090   Protein with unknown function                                                                       
  An17g01000   Putative anion transporter                                                                          

Taken from AspGD (<http://www.ncbi.nlm.nih.gov/pubmed/?term=aspGD>).

It is therefore striking that, in contrast to the limited overlap of individual antifungal‐responsive genes with *ΔugmA*‐responsive genes, the transcription factor binding site enrichment analysis showed remarkable similarities and identified RlmA and MsnA transcription factor binding sites as overrepresented under all conditions (Fig. [6](#cmi12624-fig-0006){ref-type="fig"}). Possibly, these transcription factors play an important role in combination with other factors that co‐regulate and fine‐tune the expression of different target genes.

![Overview of key transcription factors and some of their putative target genes involved in the cell wall salvage gene network of *A. niger* deduced from transcriptomic and phenotypic analysis. On the upper row, several cell wall stress conditions including FK506 (Calcineurin inhibitor), CFW (Calcofluor white), caspofungin (CA), *ΔugmA* (lack of galactofuranose biosynthesis), Aureobasidin A (AbaA) and fenpropimorph (FP). Arrows indicate (putative) signalling events between and the proteins involved in signalling based on transcriptomic or functional genomics studies. Boxed genes are the possible target genes of various transcription factors and the relation with the inducing condition. Major biological processes affected by the different treatments are depicted under the boxed genes. Despite limited overlap of the target genes induced by chemical compounds and in the *ΔugmA* mutant, the RlmA, MsnA and CrzA transcription factors are likely to play a key role in orchestrating the response.](CMI-18-1268-g006){#cmi12624-fig-0006}

Growth analysis of the *ΔugmA/ΔrlmA* and *ΔugmA/ΔmsnA* double mutants indicated an important role of the RlmA and MsnA transcription factors in securing CWI of the *ΔugmA* mutant. It will be of interest in future studies to determine the cell wall composition of the double mutants in comparison with single mutants and to identify RlmA or MsnA target genes via transcriptome analysis of CHIPseq analysis. In contrast to RlmA and MsnA, the role of SteA seems to be dispensable for the *ΔugmA* mutant, although its binding site was overrepresented in the *ΔugmA* up‐regulated gene set. In. *S. cerevisiae,* the ScSte12 transcription factor is activated by the ScFus3/ScKss1 MAPK signalling cascade and is responsible for the activation of genes involved in mating or pseudohyphal growth (Roberts and Fink, [1994](#cmi12624-bib-0044){ref-type="ref"}). In agreement with this, ScSte12 is involved in the regulation of fungal development and pathogenicity in various filamentous fungi (see for review Wong Sak Hoi and Dumas, 2010). Single deletion of the *ScSTE12* homolog in *A. niger* did not result in a detectable growth phenotype under the selected culture conditions (Fig. [4](#cmi12624-fig-0004){ref-type="fig"}, and data not shown). The role of the PacC and CrzA transcription factors in rescuing the *ΔugmA* strain is more difficult to examine as single deletion of the corresponding genes in itself results in a severe growth phenotype (Fig. [4](#cmi12624-fig-0004){ref-type="fig"}). However, both transcription factors have been shown to be involved in fungal cell wall remodelling. In *S. cerevisiae,* the ScRim101/PacC pathway is essential for cell wall assembly in the absence of CWI signalling created by disrupting the Sc*SLT2/ScMPK1* gene (Castrejon *et al.,* [2006](#cmi12624-bib-0007){ref-type="ref"}), indicating that the ScPkc1--Slt2 CWI pathway and the ScRim101/PacC pathway are partially redundant. In *Cryptococcus neoformans*, deletion of Rim101 results in down‐regulation of several cell wall‐related genes, indicating that Rim101 is important for their expression (O\'Meara *et al.,* [2014](#cmi12624-bib-0034){ref-type="ref"}). Several studies have shown that the Crz1/CrzA transcription factor is also important for cell wall remodelling. An important role of the calcium/calcineurin‐responsive transcription factor for cell wall maintenance was first discovered in *S. cerevisiae* (Yoshimoto *et al.,* [2002](#cmi12624-bib-0051){ref-type="ref"}), but its role has been shown to be conserved in filamentous fungi, including *Aspergillus* species (Steinbach *et al*., [2007](#cmi12624-bib-0046){ref-type="ref"}; Fortwendel *et al*., [2010](#cmi12624-bib-0070){ref-type="ref"}; Fiedler *et al.,* [2014](#cmi12624-bib-0017){ref-type="ref"}). A role for CrzA‐mediated cell wall remodelling in the *ΔugmA* mutant was not inferred from the TF enrichment analysis as the CrzA transcription factor binding site was not enriched in the *ΔugmA*‐upregulated gene set. However, the phenotype of the *ΔugmA/ΔcrzA* double mutant at 37 °C does suggest an important role for CrzA in cell wall remodelling in the *ΔugmA* mutant at least at higher temperatures. As in *Candida albicans* the calcineurin/Crz1p pathway is activated in response to membrane stress (Zakrzewska *et al.,* [2005](#cmi12624-bib-0052){ref-type="ref"}), this might imply that deletion of *ugmA* does result in significant membrane stress.

Several studies have shown that cross‐talk between several stress response pathways or pathways acting in parallel is important to cope with cell wall stress (Burgwun Fuchs and Mylonakis, [2009](#cmi12624-bib-0022){ref-type="ref"}; Ouedraogo *et al.,* [2011](#cmi12624-bib-0035){ref-type="ref"}; Verwer *et al.,* [2012](#cmi12624-bib-0049){ref-type="ref"}; García *et al.,* [2015](#cmi12624-bib-0023){ref-type="ref"}). Efficient inhibition of a fungal pathogen can be accomplished by the combination of two drugs, one targeting cell wall synthesis and the other by interfering with the adaptive mechanism. An elegant and promising example for such an approach is the recent study by Valiante *et al*., who showed that the efficacy of caspofungin treatment was strongly increased by simultaneous inhibition of the High Osmolarity Glycerol response pathway by the newly identified drug humidimycin (Valiante *et al.,* [2015](#cmi12624-bib-0048){ref-type="ref"}). Our study has shown that inhibition of Gal*f* biosynthesis is by itself not fungicidal, but that Gal*f‐*deficient cells become highly dependent on the RlmA and MsnA transcription factors. The strong synthetic growth defect of the double mutants shows the importance of activation of the CWI pathway to maintain CWI in the absence of Gal*f* biosynthesis and underscores the potential of using combinations of antifungals that act synergistically to combat fungal infections.

Experimental procedures {#cmi12624-sec-0002}
=======================

Strains and culture conditions {#cmi12624-sec-0003}
------------------------------

*Aspergillus niger* strains used in this study are listed in Table [10](#cmi12624-tbl-0010){ref-type="table-wrap"}. Strains were cultivated in [m]{.ul}inimal [m]{.ul}edium (MM) (Bennett and Lasure, [1991](#cmi12624-bib-0004){ref-type="ref"}) containing 1% (w/v) glucose (or other carbon sources as indicated), 7 mM KCl, 11 mM KH~2~PO~4~, 70 mM NaNO~3~, 2 mM MgSO~4~, 76 nM ZnSO~4~, 178 nM H~3~BO~3~, 25 nM MnCl~2~, 18 nM FeSO~4~, 7.1 nM CoCl~2~, 6.4 nM CuSO~4~, 6.2 nM Na~2~MoO~4~, 174 nM EDTA; or in [c]{.ul}omplete [m]{.ul}edium (CM) containing, in addition to MM, 0.1% (w/v) casamino acids and 0.5% (w/v) yeast extract. When required, 10 mM uridine, 2.5 µg/ml nicotinamide or 100 µg/ml hygromycin was added. Fermentation medium (FM) initially adjusted to pH 3 is composed of 0.75% glucose, 0.45% NH~4~Cl, 0.15% KH~2~PO~4~, 0.05%KCl, 0.05% MgSO~4~, 0.1% trace element solution and 0.003% yeast extract as described (Jørgensen *et al.,* [2010](#cmi12624-bib-0028){ref-type="ref"}).

###### 

Strains used in this study.

  Strain    Genotype                                                                  Description                                                Reference
  --------- ------------------------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------------
  N402      *cspA1*                                                                   derivative of N400                                         Bos *et al.,* 1988
  MA87.6    *cspA1, pyrG378, kusA::amdS, ugmA::AOpyrG*                                *ΔugmA* in MA70.15                                         Damveld *et al.,* [2008](#cmi12624-bib-0010){ref-type="ref"}
  MA169.4   *cspA1, pyrG378, kusA::DR‐amdS‐DR*                                        *ku70* disruption in AB4.1                                 Carvalho *et al.,* [2010](#cmi12624-bib-0006){ref-type="ref"}
  MA234.1   *cspA1, kusA::DR‐amdS‐DR*                                                 Restored *pyrG* in MA169.4                                 This study
  MA417.1   *cspA1, kusA::DR‐amdS‐DR, rlmA::hygB*                                     *ΔrlmA* in MA234.1                                         This study
  MA306.1   *cspA1, kusA::DR‐amdS‐DR, crzA::hygB*                                     *ΔcrzA* in MA234.1                                         This study
  MA513.1   *cspA1, kusA::DR‐amdS‐DR, msnA::hygB*                                     *ΔmsnA* in MA234.1                                         This study
  MA527.2   *cspA1, kusA::DR‐amdS‐DR, steA::hygB*                                     *ΔsteA* in MA234.1                                         This study
  EA13.1    *cspA1, kusA::DR‐amdS‐DR, pacC::hygB*                                     *ΔpacC* in MA234.1                                         Alazi *et al.,* in prep
  MA322.1   *cspA1, pyrG378, kusA::DR‐amdS‐DR, ΔnicB::AOpyrG*                         *ΔnicB::AOpyrG* in MA169.4                                 Niu *et al.,* 2016
  MA323.1   *cspA1, pyrG378, kusA::DR‐amdS‐DR, ΔnicB*                                 *ΔnicB::AOpyrG* in MA169.4, followed by *AOpyrG* loopout   Niu *et al.,* 2016
  MB2.1     *cspA1, pyrG378, kusA::DR‐amdS‐DR, ΔnicB, ugmA::AnidnicB*                 *ΔugmA* in MA323.1                                         This study
  MB3.1     *cspA1, pyrG378, kusA::DR‐amdS‐DR, ΔnicB, ugmA::AnidnicB, rlmA::AOpyrG*   *ΔugmAΔrlmA* (*ΔrlmA* in MB2.1)                            This study
  MB4.1     *cspA1, pyrG378, kusA::DR‐amdS‐DR, ΔnicB, ugmA::AnidnicB, crzA::AOpyrG*   *ΔugmAΔcrzA* (*ΔcrzA* in MB2.1)                            This study
  MB5.1     *cspA1, pyrG378, kusA::DR‐amdS‐DR, ΔnicB, ugmA::AnidnicB, msnA::AOpyrG*   *ΔugmAΔmsnA* (*ΔmsnA* in MB2.1)                            This study
  MB6.1     *cspA1, pyrG378, kusA::DR‐amdS‐DR, ΔnicB, ugmA::AnidnicB, steA::AOpyrG*   *ΔugmAΔsteA* (*ΔsteA* in MB2.1)                            This study
  MB7.1     *cspA1, pyrG378, kusA::DR‐amdS‐DR, ΔnicB, ugmA::AnidnicB, pacC::AOpyrG*   *ΔugmAΔpacC* (*ΔpacC* in MB2.1)                            This study

Protein extraction and immunoblotting analysis {#cmi12624-sec-0004}
----------------------------------------------

1 × 10^7^ conidia of *A. niger* N402 and *ΔugmA* strain were grown at 30 °C (200 rpm) in liquid CM during 18, 24 and 36 h or 24, 36 and 48 h for the wild‐type and Δ*ugmA* strains respectively. For protein extraction, 0.5 ml of lysis buffer added to the ground mycelia as described previously (Rocha *et al.,* [2015](#cmi12624-bib-0043){ref-type="ref"}). The supernatants were collected and the protein concentrations were determined according to the Lowry method modified by Hartree (Hartree, [1972](#cmi12624-bib-0025){ref-type="ref"}). A 50 µg quantity of protein from each sample was resolved in a 12% (w/v) SDS‐PAGE and transferred to polyvinylidene difluoride (PVDF) membranes (GE Health Care). The phosphorylation of MpkA was examined using anti‐phospho p44/42 and the total amount of MpkA was detected by using the anti p44/42 MAPK antibody (9101 and 4370, respectively; Cell Signaling Technologies) according to the manufacturer\'s instructions. The primary antibody was detected with HRP‐conjugated secondary antibody raised in rabbits (A0545; Sigma). Anti γ‐tubulin (yN‐20; Santa Cruz Biotechnology) was used as the loading control in these experiments. Anti γ‐tubulin antibodies were detected with peroxidase HRP‐conjugated secondary antibody (sc‐2020; Santa Cruz Biotechnology). All the primary antibody detections here were performed at room temperature with the specified secondary antibody in TBST buffer (137 mM NaCl, 20 mM Tris and 0.1% Tween‐20). Chemoluminescent detection was performed by using an ECL Prime Western Blot detection kit (GE Health Care). Images were generated by exposing the membranes to the ChemiDoc XRS gel imaging system (BioRad). The images were subjected to densitometric analysis in ImageJ software to achieve the ratio of phosphorylated/total MpkA for each time point.

Construction of single and double mutant knock‐out mutants {#cmi12624-sec-0005}
----------------------------------------------------------

For the construction of single deletion mutants, flanks of the gene to be deleted were PCR‐amplified and split marker fragments with selection markers *AOpyrG* or *hygB* were created using fusion PCR (Arentshorst *et al.,* [2015](#cmi12624-bib-0003){ref-type="ref"}). The split marker fragments were either transformed to strain MA169.4 (*ku70^−^*, *pyrG^−^*) for *pyrG* selection (Carvalho *et al.,* [2010](#cmi12624-bib-0006){ref-type="ref"}) or to strain MA234.1 (*ku70^−^*) for *hygB* selection. Strain MA234.1 (*ku70^−^*) was obtained by transformation of strain MA169.4 (*ku70^−^*, *pyrG^−^*) with a 3.8 kb *Xba*I fragment containing the *A. niger pyrG* gene, resulting in the full restoration of the *pyrG* locus in strain MA234.1. For the construction of *ΔugmA/*transcription factor double deletion mutants, parental strain MA323.1 (*ΔnicB^‐^*, *pyrG^‐^*) (Niu *et al*., 2016) was transformed with *ugmA‐nicB* split marker fragments (Arentshorst *et al.,* [2015](#cmi12624-bib-0003){ref-type="ref"}) to obtain *ΔugmA* mutant strain MB2.1 (*ΔugmA::nicB*, *pyrG^−^*). *Aspergillus oryzae pyrG* (*AOpyrG)* split marker fragments of all transcription factors were transformed to this strain, resulting in double deletion mutants. All strains used in this study are listed in Table [10](#cmi12624-tbl-0010){ref-type="table-wrap"}. All primers used in this study are listed in [Table S7](#cmi12624-supitem-0001){ref-type="supplementary-material"} Proper deletion of the genes in the various mutants was verified by Southern blot analysis or diagnostic PCR (data not shown).

Bioreactor cultivation conditions {#cmi12624-sec-0006}
---------------------------------

Details on the medium composition and batch cultivation conditions with 6.6 L BioFlo3000 bioreactors (New Brunswick Scientific, NJ, USA) were performed as described by Jørgensen *et al.* ([2010](#cmi12624-bib-0028){ref-type="ref"}), except that glucose was used as a carbon source in this study. The cultivation program involves two consecutive phases: in the first phase, carried at out 30 °C and at pH 3, head space aeration was used and the agitation speed was kept at 250 rpm for the first 5 h. In the second phase, after spore germination, the pH was slowly increased by the addition of NaOH to the desired pH value (set at 3.0, 4.0, 5.0 or 6.0) and increased agitation speed (750 rpm) and sparger aeration. At the same time, 0.01% (v/v) polypropyleneglycol P2000 was added as antifoam agent. Biomass was determined by weighing lyophilized mycelium from a known mass of culture broth. Culture broth was filtered through GF/C glass microfiber filters (Whatman). The filtrate was collected and frozen for use in solute analyses. The mycelium was washed with demineralised water, rapidly frozen in liquid nitrogen and stored at −80 °C for RNA isolation and microscopic analyses. Mycelium samples harvested from bioreactor runs JH04 and JH08 (N402 at pH 5.0) and JH05 and JH09 (*ΔugmA* at pH 5.0) were used for RNA extraction. Dot blot analysis using the anti‐galactofuranose antibody L10 (Heesemann *et al.,* [2011](#cmi12624-bib-0026){ref-type="ref"}) was performed as described (Park *et al.,* [2014](#cmi12624-bib-0036){ref-type="ref"})

RNA isolation and quality control {#cmi12624-sec-0007}
---------------------------------

Mycelium intended for gene‐expression analyses was separated from culture medium and frozen in liquid nitrogen within 15--20 s from sampling and stored at −80 °C. RNA was extracted from mycelium in liquid nitrogen using TRIzol reagent (InVitrogen). Frozen ground mycelium (≈200 mg) was directly suspended in 800 µl Trizol reagent and vortexed vigorously for 1 min. After centrifugation for 5 min at 10 000 ×*g*, 450 µl of the supernatant was transferred to a new tube. Chloroform (150 µl) was added and after a 3 min incubation at room temperature, samples were centrifuged and the upper aqueous phase was transferred to a new tube to which 400 µl of isopropanol was added, followed by a 10 min incubation at room temperature and centrifugation for 10 min at 10,000 ×*g*. The pellet was washed with 75% (v/v) ethanol and finally dissolved in 100 µl H~2~O. RNA samples for RNA sequencing were additionally purified on NucleoSpin RNA II columns (Machery‐Nagel) according to the manufacturer\'s instructions. RNA quantity and quality were determined using a Nanodrop ND1000 spectrophotometer.

RNA seq analysis {#cmi12624-sec-0008}
----------------

RNA sequencing was outsourced to ServiceXS (Leiden, The Netherlands). cDNA library constructions were performed using the Illumina mRNA‐Seq Sample preparation kit according to the instructions of the supplier. In brief, mRNA was isolated from total RNA using oligo‐dT magnetic beads. After fragmentation of the mRNA, cDNA synthesis was performed and the cDNA was ligated with the sequencing adapters before PCR amplification of the resulting product. The quality and yield after sample preparation were measured with a DNA 1000 Lab‐on‐a‐Chip. Clustering and mRNA sequencing using the Illumina cBot and HiSeq 2000 were performed according to the manufacturer\'s protocol. For each RNA sample at least 3.2 Gb of sequence data were obtained that passed the quality control (% ≥ Q30). Image analysis, base calling and quality checks were performed with the Illumina data analysis pipeline RTA v1.13.48 and/or OLBv1.9 and CASAVA v1.8.2. Quality‐filtered sequence tags are available upon request.

Transcriptomic data analysis {#cmi12624-sec-0009}
----------------------------

RNA‐Seq analysis was performed essentially as described previously (Wang *et al.,* [2015](#cmi12624-bib-0050){ref-type="ref"}) except for the transfer of genome annotations. Annotations were transferred from the CBS 513.88 genome to the N402 genome based on bidirectional alignments created with LAST (version 417) (Kiełbasa *et al*., [2011](#cmi12624-bib-0065){ref-type="ref"}), with tandem repeat sections masked with TRF (Benson, [1999](#cmi12624-bib-0056){ref-type="ref"}). Alignments were combined and chained using CLASP (Otto *et al*., [2011](#cmi12624-bib-0071){ref-type="ref"}). Gaps in the global alignment were improved by performing realignment using either LAST (for large gaps, in sensitive mode) or Needleman--Wunsch (for smaller gaps). Chains with scores \> 150 were accepted for alignment transfer. In total, 13 412 (of 14070) genes were transferred. The normalized, RNAseq‐based expression data are summarized in [Table S8](#cmi12624-supitem-0001){ref-type="supplementary-material"}.

Gene ontology (GO) and transcription factor binding site enrichment analysis {#cmi12624-sec-0010}
----------------------------------------------------------------------------

Over‐represented GO terms in sets of differentially expressed genes (FDR at q \< 0.05) were determined by Fisher\'s exact test (Fisher, [1922](#cmi12624-bib-0018){ref-type="ref"}). An improved GO annotation for the *A. niger* CBS 513.88 genome was based on orthology mappings from *A. nidulans* FGSC A4 (Nitsche *et al.,* [2012a](#cmi12624-bib-0032){ref-type="ref"}, [2012b](#cmi12624-bib-0033){ref-type="ref"}). Transcription factor binding site enrichment analysis of genes differentially higher expressed in the *ΔugmA* mutant was performed using a Perl script named the transcription factor binding site finder (TFBSF) as described previously (Meyer *et al.,* [2009](#cmi12624-bib-0030){ref-type="ref"}).
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======================

**Table S1.** Differentially expressed genes up‐regulated in *ΔugmA* mutant.

**Table S2.** Differentially expressed genes down‐regulated in *ΔugmA* mutant.

**Table S3.** GO‐terms (Biological Processes) over‐represented in the genes up‐regulated in the *ΔugmA* mutant.

**Table S4.** GO‐terms (Biological Processes) over‐represented in the genes down‐regulated in the *ΔugmA* mutant.

**Table S5.** Transcription factor binding sites enriched in the promoter of regions of genes up‐regulated in the *ΔugmA* mutant.

**Table S6.** Gene identities of genes up‐regulated after treatment with caspofungin, fenpropimorph, aureobasidin A, FK506 and in the *ΔugmA* mutant.

**Table S7.** Primers used in this study.

**Table S8.** RNAseq expression data N402 and *ΔugmA* mutant.
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